Monographs on the medicinal uses of plant drugs. Exeter, UK: European Scientific Co-op Phytother, 1997.
Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Trans. S. Klein. Boston, MA: American Botanical Council, 1998.
Tyler VE. Herbs of Choice. Binghamton, NY: Pharmaceutical Products Press, 1994.
Newall CA, Anderson LA, Philpson JD. Herbal Medicine: A Guide for Healthcare Professionals. London, UK: The Pharmaceutical Press, 1996.
Foster S, Tyler VE. Tyler's Honest Herbal: A Sensible Guide to the Use of Herbs and Related Remedies. 3rd ed., Binghamton, NY: Haworth Herbal Press, 1993.
The Review of Natural Products by Facts and Comparisons. St. Louis, MO: Wolters Kluwer Co., 1999.
Gerhardt AL, Gallo NB. Full-fat rice bran and oat bran similarly reduce hypercholesterolemia in humans. J Nutr 1998;128:865-9.
Durk H, Haase K, Saal J, et al. Nephrotic syndrome after injections of bovine cartilage and marrow extract. [letter] Lancet 1989;1:614.
Ashar B, Vargo E. Shark cartilage-induced hepatitis [letter]. Ann Intern Med 1996;125:780-1.
Davy BM, Melby CL, Beske SD, et al. Oat consumption does not affect resting casual and ambulatory 24-h arterial blood pressure in men with high-normal blood pressure to stage I hypertension. J Nutr 2002;132:394-8..
Borchers AT, Stern JS, Hackman RM, et al. Mushrooms, tumors, and immunity. Proc Soc Exp Biol Med 1999;221:281-293.
Ooi VE, Liu F. Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem 2000;7:715-29.
Electronic Code of Federal Regulations. Title 21. Part 182 -- Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 1999;69:30-42.
Pick ME, Hawrysh ZJ, Gee MI, et al. Oat bran concentrate bread products improve long-term control of diabetes: a pilot study. J Am Diet Assoc 1996;96:1254-61.
Wood PJ, Braaten JT, Scott FW, et al. Effect of dose and modification of viscous properties of oat gum on plasma glucose and insulin following an oral glucose load. Br J Nutr 1994;72:731-43.
Davidson MH, Dugan LD, Burns JH, et al. The hypocholesterolemic effects of beta-glucan in oatmeal and oat bran. JAMA 1991;265:1833-9.
Lovegrove JA, Clohessy A, Milon H, et al. Modest doses of beta-glucan do not reduce concentrations of potentially atherogenic lipoproteins. Am J Clin Nutr 2000;72:49-55.
Braaten JT, Wood PJ, Scott FW, et al. Oat beta-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects. Eur J Clin Nutr 1994;48:465-74.
Ross GD, Vetvicka V, Yan J, et al. Therapeutic intervention with complement and beta-glucan in cancer. Immunopharmacology 1999;42:61-74.
Muller A, Rice PJ, Ensley HE, et al. Receptor binding and internalization of a water-soluble (1-->3)-beta-D-glucan biologic response modifier in two monocyte/macrophage cell lines. J Immunol 1996;156:3418-25.
Yan J, Vetvicka V, Xia Y, et al. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18). J Immunol 1999;163:3045-52.
Penna C, Dean PA, Nelson H. Pulmonary metastases neutralization and tumor rejection by in vivo administration of beta glucan and bispecific antibody. Int J Cancer 1996;65:377-382.
Williams DL, Pretus HA, McNamee RB, et al. Development, physicochemical characterization and preclinical efficacy evaluation of a water soluble glucan sulfate derived from Saccharomyces cerevisiae. Immunopharmacology 1991;22:139-55.
Mueller A, Raptis J, Rice PJ, et al. The influence of glucan polymer structure and solution conformation on binding to (1-->3)-beta-D-glucan receptors in a human monocyte-like cell line. Glycobiology 2000;10:339-46.
Sherwood ER, Williams DL, McNamee RB, et al. Enhancement of interleukin-1 and interleukin-2 production by soluble glucan. Int J Immunopharmacol 1987;9:261-7.
Portera CA, Love EJ, Memore L, et al. Effect of macrophage stimulation on collagen biosynthesis in the healing wound. Am Surg 1997;63:125-31.
Liang J, Melican D, Cafro L, et al. Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with PGG-glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity. Int J Immunopharmacol 1998;20:595-614.
Wakshull E, Brunke-Reese D, Lindermuth J, et al. PGG-Glucan, a soluble beta-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-kappa B-like factor in human PMN: evidence for a glycosphingolipid beta-(1,3)-glucan receptor. Immunopharmacology 1999;4:89-107.
Tsiapali E, Whaley S, Kalbfleisch J, et al. Glucans exhibit weak antioxidant activity, but stimulate macrophage free radical activity. Free Radic Biol Med 2001;30:393-402.
Williams DL, Sherwood ER, Browder IW, et al. Pre-clinical safety evaluation of soluble glucan. Int J Immunopharmacol 1988;10;405-14.
Duvic M, Reisman M, Finley V, et al. Glucan-induced keratoderma in acquired immunodeficiency syndrome. Arch Dermatol 1987;123:751-6.
Yoshioka S, Ohno N, Miura T, et al. Immunotoxicity of soluble beta-glucans induced by indomethacin treatment. FEMS Immunol Med Microbiol 1998;21:171-179.
Okamura K, Suzuki M, Chihara T, et al. Clinical evaluation of schizophyllan combined with irradiation in patients with cervical cancer. A randomized controlled study. Cancer 1986;58:865-72.
Kimura Y, Tojima H, Fukase S, Takeda K. Clinical evaluation of sizofilan as assistant immunotherapy in treatment of head and neck cancer. Acta Otolaryngol Suppl 1994;511:192-5.
Miyazaki K, Mizutani H, Katabuchi H, et al. Activated (HLA-DR+) T-lymphocyte subsets in cervical carcinoma and effects of radiotherapy and immunotherapy with sizofiran on cell-mediated immunity and survival. Gynecol Oncol 1995;56:412-40.
Arinaga S, Karimine N, Takamuku K, et al. Enhanced induction of lymphokine-activated killer activity after lentinan administration in patients with gastric carcinoma. Int J Immunopharmac 1992;14:535-539.
Matsuoka H, Seo Y, Wakasugi H, et al. Lentinan potentiates immunity and prolongs the survival time of some patients. Anticancer Res 1997;17:2751-5.
Gordon M, Bihari B, Goosby E, et al. A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial. J Med 1998;29:305-30.
Browder W, Williams D, Pretus H, et al. Beneficial effect of enhanced macrophage function in the trauma patient. Ann Surg 1990;211:605-12; discussion 612-3.
Babineau TJ, Marcello P, Swails W, et al. Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients. Ann Surg 1994;220:601-9.
Babineau TJ, Hackford A, Kenler A, et al. A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients. Arch Surg 1994;129:1204-10.
Dellinger EP, Babineau TJ, Bleicher P, et al. Effect of PGG-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations. Betafectin Gastrointestinal Study Group. Arch Surg 1999;134:977-83.
Nicolosi R, Bell SJ, Bistrian BR, et al. Plasma lipid changes after supplementation with beta-glucan fiber from yeast. Am J Clin Nutr 1999;70:208-12.
Bell S, Goldman VM, Bistrian BR, et al. Effect of beta-glucan from oats and yeast on serum lipids. Crit Rev Food Sci Nutr 1999;39:189-202.
Van Horn L, Liu K, Gerber J, et al. Oats and soy in lipid-lowering diets for women with hypercholesterolemia: is there synergy? J Am Diet Assoc 2001;101:1319-25.
Kerckhoffs DA, Hornstra G, Mensink RP. Cholesterol-lowering effect of beta-glucan from oat bran in mildly hypercholesterolemic subjects may decrease when beta-glucan is incorporated into bread and cookies. Am J Clin Nutr 2003;78:221-7..
Keogh GF, Cooper GJ, Mulvey TB, et al. Randomized controlled crossover study of the effect of a highly beta-glucan-enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men. Am J Clin Nutr 2003;78:711-18.
Lupton JR, Robinson MC, Morin JL. Cholesterol-lowering effect of barley bran flour and oil. J Am Diet Assoc 1994;94:65-70..
Behall KM, Scholfield DJ, Hallfrisch J. Lipids significantly reduced by diets containing barley in moderately hypercholesterolemic men. J Am Coll Nutr 2004;23:55-62.
AbuMweis SS, Jew S, Ames NP. Beta-glucan from barley and its lipid-lowering capacity: a meta-analysis of randomized, controlled trials. Eur J Clin Nutr 2010;64:1472-80.
Behall, K. M., Scholfield, D. J., and Hallfrisch, J. Diets containing barley significantly reduce lipids in mildly hypercholesterolemic men and women. Am.J.Clin.Nutr. 2004;80(5):1185-1193.
Casiraghi, M. C., Garsetti, M., Testolin, G., and Brighenti, F. Post-prandial responses to cereal products enriched with barley beta-glucan. J Am Coll.Nutr 2006;25(4):313-320.
Poppitt, S. D., van Drunen, J. D., McGill, A. T., Mulvey, T. B., and Leahy, F. E. Supplementation of a high-carbohydrate breakfast with barley beta-glucan improves postprandial glycaemic response for meals but not beverages. Asia Pac J Clin Nutr 2007;16(1):16-24.
Keenan, J. M., Goulson, M., Shamliyan, T., Knutson, N., Kolberg, L., and Curry, L. The effects of concentrated barley beta-glucan on blood lipids in a population of hypercholesterolaemic men and women. Br J Nutr 2007;97(6):1162-1168.
Shimizu, C., Kihara, M., Aoe, S., Araki, S., Ito, K., Hayashi, K., Watari, J., Sakata, Y., and Ikegami, S. Effect of high beta-glucan barley on serum cholesterol concentrations and visceral fat area in Japanese men--a randomized, double-blinded, placebo-controlled trial. Plant Foods Hum.Nutr. 2008;63(1):21-25.
Nilsson, A. C., Ostman, E. M., Holst, J. J., and Bjorck, I. M. Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast. J.Nutr. 2008;138(4):732-739.
McIntosh, G. H., Whyte, J., McArthur, R., and Nestel, P. J. Barley and wheat foods: influence on plasma cholesterol concentrations in hypercholesterolemic men. Am.J.Clin.Nutr. 1991;53(5):1205-1209.
Smith, K. N., Queenan, K. M., Thomas, W., Fulcher, R. G., and Slavin, J. L. Physiological effects of concentrated barley beta-glucan in mildly hypercholesterolemic adults. J.Am.Coll.Nutr. 2008;27(3):434-440.
Peters, H. P., Boers, H. M., Haddeman, E., Melnikov, S. M., and Qvyjt, F. No effect of added beta-glucan or of fructooligosaccharide on appetite or energy intake. Am.J.Clin.Nutr. 2009;89(1):58-63.
Liljeberg, H. G., Granfeldt, Y. E., and Bjorck, I. M. Products based on a high fiber barley genotype, but not on common barley or oats, lower postprandial glucose and insulin responses in healthy humans. J.Nutr. 1996;126(2):458-466.
Bourdon, I., Yokoyama, W., Davis, P., Hudson, C., Backus, R., Richter, D., Knuckles, B., and Schneeman, B. O. Postprandial lipid, glucose, insulin, and cholecystokinin responses in men fed barley pasta enriched with beta-glucan. Am.J.Clin.Nutr. 1999;69(1):55-63.
Cleary, J. A., Kelly, G. E., and Husband, A. J. The effect of molecular weight and beta-1,6-linkages on priming of macrophage function in mice by (1,3)-beta-D-glucan. Immunol Cell Biol 1999;77(5):395-403.
Onning, G., Wallmark, A., Persson, M., Akesson, B., Elmstahl, S., and Oste, R. Consumption of oat milk for 5 weeks lowers serum cholesterol and LDL cholesterol in free-living men with moderate hypercholesterolemia. Ann.Nutr.Metab 1999;43(5):301-309.
Delatte, S. J., Evans, J., Hebra, A., Adamson, W., Othersen, H. B., and Tagge, E. P. Effectiveness of beta-glucan collagen for treatment of partial-thickness burns in children. J.Pediatr.Surg. 2001;36(1):113-118.
Katz, D. L., Nawaz, H., Boukhalil, J., Giannamore, V., Chan, W., Ahmadi, R., and Sarrel, P. M. Acute effects of oats and vitamin E on endothelial responses to ingested fat. Am.J.Prev.Med. 2001;20(2):124-129.
Rami, B., Zidek, T., and Schober, E. Influence of a beta-glucan-enriched bedtime snack on nocturnal blood glucose levels in diabetic children. J.Pediatr.Gastroenterol.Nutr. 2001;32(1):34-36.
Battilana, P., Ornstein, K., Minehira, K., Schwarz, J. M., Acheson, K., Schneiter, P., Burri, J., Jequier, E., and Tappy, L. Mechanisms of action of beta-glucan in postprandial glucose metabolism in healthy men. Eur.J.Clin.Nutr. 2001;55(5):327-333.
Takahashi, H., Ohno, N., Adachi, Y., and Yadomae, T. Association of immunological disorders in lethal side effect of NSAIDs on beta-glucan-administered mice. FEMS Immunol.Med.Microbiol. 2001;31(1):1-14.
Juntunen, K. S., Niskanen, L. K., Liukkonen, K. H., Poutanen, K. S., Holst, J. J., and Mykkanen, H. M. Postprandial glucose, insulin, and incretin responses to grain products in healthy subjects. Am.J.Clin.Nutr. 2002;75(2):254-262.
Jenkins, D. J., Kendall, C. W., Vuksan, V., Vidgen, E., Parker, T., Faulkner, D., Mehling, C. C., Garsetti, M., Testolin, G., Cunnane, S. C., Ryan, M. A., and Corey, P. N. Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial. Am.J.Clin.Nutr. 2002;75(5):834-839.
Pins, J. J., Geleva, D., Keenan, J. M., Frazel, C., O'Connor, P. J., and Cherney, L. M. Do whole-grain oat cereals reduce the need for antihypertensive medications and improve blood pressure control? J.Fam.Pract. 2002;51(4):353-359.
Keenan, J. M., Pins, J. J., Frazel, C., Moran, A., and Turnquist, L. Oat ingestion reduces systolic and diastolic blood pressure in patients with mild or borderline hypertension: a pilot trial. J.Fam.Pract. 2002;51(4):369.
Kabir, M., Oppert, J. M., Vidal, H., Bruzzo, F., Fiquet, C., Wursch, P., Slama, G., and Rizkalla, S. W. Four-week low-glycemic index breakfast with a modest amount of soluble fibers in type 2 diabetic men. Metabolism 2002;51(7):819-826.
Jenkins, A. L., Jenkins, D. J., Zdravkovic, U., Wursch, P., and Vuksan, V. Depression of the glycemic index by high levels of beta-glucan fiber in two functional foods tested in type 2 diabetes. Eur.J.Clin.Nutr. 2002;56(7):622-628.
Davy, B. M., Davy, K. P., Ho, R. C., Beske, S. D., Davrath, L. R., and Melby, C. L. High-fiber oat cereal compared with wheat cereal consumption favorably alters LDL-cholesterol subclass and particle numbers in middle-aged and older men. Am.J.Clin.Nutr. 2002;76(2):351-358.
Andersson, M., Ellegard, L., and Andersson, H. Oat bran stimulates bile acid synthesis within 8 h as measured by 7alpha-hydroxy-4-cholesten-3-one. Am.J.Clin.Nutr. 2002;76(5):1111-1116.
Yun, C. H., Estrada, A., Van Kessel, A., Park, B. C., and Laarveld, B. Beta-glucan, extracted from oat, enhances disease resistance against bacterial and parasitic infections. FEMS Immunol.Med.Microbiol. 1-21-2003;35(1):67-75.
Maki, K. C., Shinnick, F., Seeley, M. A., Veith, P. E., Quinn, L. C., Hallissey, P. J., Temer, A., and Davidson, M. H. Food products containing free tall oil-based phytosterols and oat beta-glucan lower serum total and LDL cholesterol in hypercholesterolemic adults. J.Nutr. 2003;133(3):808-813.
Young, S. H., Robinson, V. A., Barger, M., Frazer, D. G., Castranova, V., and Jacobs, R. Partially opened triple helix is the biologically active conformation of 1 &rarr3-beta-glucans that induces pulmonary inflammation in rats. J.Toxicol.Environ.Health A 3-28-2003;66(6):551-564.
Uusitupa, M. I., Ruuskanen, E., Makinen, E., Laitinen, J., Toskala, E., Kervinen, K., and Kesaniemi, Y. A. A controlled study on the effect of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: relation to apolipoprotein E phenotype. J.Am.Coll.Nutr. 1992;11(6):651-659.
Hiss, S. and Sauerwein, H. Influence of dietary ss-glucan on growth performance, lymphocyte proliferation, specific immune response and haptoglobin plasma concentrations in pigs. J.Anim Physiol Anim Nutr.(Berl) 2003;87(1-2):2-11.
Howarth, N. C., Saltzman, E., McCrory, M. A., Greenberg, A. S., Dwyer, J., Ausman, L., Kramer, D. G., and Roberts, S. B. Fermentable and nonfermentable fiber supplements did not alter hunger, satiety or body weight in a pilot study of men and women consuming self-selected diets. J.Nutr. 2003;133(10):3141-3144.
Reyna, N. Y., Cano, C., Bermudez, V. J., Medina, M. T., Souki, A. J., Ambard, M., Nunez, M., Ferrer, M. A., and Inglett, G. E. Sweeteners and beta-glucans improve metabolic and anthropometrics variables in well controlled type 2 diabetic patients. Am.J Ther. 2003;10(6):438-443.
Li, J., Kaneko, T., Qin, L. Q., Wang, J., and Wang, Y. Effects of barley intake on glucose tolerance, lipid metabolism, and bowel function in women. Nutrition 2003;19(11-12):926-929.
Chrouser, K. L., Fick, F., Goel, A., Itano, N. B., Sweat, S. D., and Lightner, D. J. Carbon coated zirconium beads in beta-glucan gel and bovine glutaraldehyde cross-linked collagen injections for intrinsic sphincter deficiency: continence and satisfaction after extended followup. J.Urol. 2004;171(3):1152-1155.
Frank, J., Sundberg, B., Kamal-Eldin, A., Vessby, B., and Aman, P. Yeast-leavened oat breads with high or low molecular weight beta-glucan do not differ in their effects on blood concentrations of lipids, insulin, or glucose in humans. J.Nutr. 2004;134(6):1384-1388.
Hong, F., Yan, J., Baran, J. T., Allendorf, D. J., Hansen, R. D., Ostroff, G. R., Xing, P. X., Cheung, N. K., and Ross, G. D. Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol 7-15-2004;173(2):797-806.
Tsikitis, V. L., Albina, J. E., and Reichner, J. S. Beta-glucan affects leukocyte navigation in a complex chemotactic gradient. Surgery 2004;136(2):384-389.
Behall, K. M., Scholfield, D. J., and Hallfrisch, J. Comparison of hormone and glucose responses of overweight women to barley and oats. J.Am.Coll.Nutr. 2005;24(3):182-188.
Robitaille, J., Fontaine-Bisson, B., Couture, P., Tchernof, A., and Vohl, M. C. Effect of an oat bran-rich supplement on the metabolic profile of overweight premenopausal women. Ann.Nutr.Metab 2005;49(3):141-148.
Karmally, W., Montez, M. G., Palmas, W., Martinez, W., Branstetter, A., Ramakrishnan, R., Holleran, S. F., Haffner, S. M., and Ginsberg, H. N. Cholesterol-lowering benefits of oat-containing cereal in Hispanic americans. J.Am.Diet.Assoc. 2005;105(6):967-970.
Biorklund, M., van, Rees A., Mensink, R. P., and Onning, G. Changes in serum lipids and postprandial glucose and insulin concentrations after consumption of beverages with beta-glucans from oats or barley: a randomised dose-controlled trial. Eur.J.Clin.Nutr. 2005;59(11):1272-1281.
Tapola, N., Karvonen, H., Niskanen, L., Mikola, M., and Sarkkinen, E. Glycemic responses of oat bran products in type 2 diabetic patients. Nutr.Metab Cardiovasc.Dis. 2005;15(4):255-261.
Chen, J., He, J., Wildman, R. P., Reynolds, K., Streiffer, R. H., and Whelton, P. K. A randomized controlled trial of dietary fiber intake on serum lipids. Eur.J.Clin.Nutr. 2006;60(1):62-68.
Naumann, E., van Rees, A. B., Onning, G., Oste, R., Wydra, M., and Mensink, R. P. Beta-glucan incorporated into a fruit drink effectively lowers serum LDL-cholesterol concentrations. Am J Clin Nutr 2006;83(3):601-605.
Nimura, H., Mitsumori, N., Takahashi, N., Kashimura, H., Takayama, S., Kashiwagi, H., and Yanaga, K. [S-1 combined with lentinan in patients with unresectable or recurrent gastric cancer]. Gan To Kagaku Ryoho 2006;33 Suppl 1:106-109.
Aarsaether, E., Rydningen, M., Einar, Engstad R., and Busund, R. Cardioprotective effect of pretreatment with beta-glucan in coronary artery bypass grafting. Scand Cardiovasc.J 2006;40(5):298-304.
Maki, K. C., Galant, R., Samuel, P., Tesser, J., Witchger, M. S., Ribaya-Mercado, J. D., Blumberg, J. B., and Geohas, J. Effects of consuming foods containing oat beta-glucan on blood pressure, carbohydrate metabolism and biomarkers of oxidative stress in men and women with elevated blood pressure. Eur J Clin Nutr 2007;61(6):786-795.
Makelainen, H., Anttila, H., Sihvonen, J., Hietanen, R. M., Tahvonen, R., Salminen, E., Mikola, M., and Sontag-Strohm, T. The effect of beta-glucan on the glycemic and insulin index. Eur J Clin Nutr 2007;61(6):779-785.
Demir, G., Klein, H. O., Mandel-Molinas, N., and Tuzuner, N. Beta glucan induces proliferation and activation of monocytes in peripheral blood of patients with advanced breast cancer. Int Immunopharmacol. 2007;7(1):113-116.
Theuwissen, E. and Mensink, R. P. Simultaneous intake of beta-glucan and plant stanol esters affects lipid metabolism in slightly hypercholesterolemic subjects. J Nutr 2007;137(3):583-588.
Queenan, K. M., Stewart, M. L., Smith, K. N., Thomas, W., Fulcher, R. G., and Slavin, J. L. Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr.J. 2007;6:6.
Pazos, C., Moragues, M. D., Quindos, G., Ponton, J., and del Palacio, A. Diagnostic potential of (1,3)-beta-D-glucan and anti-Candida albicans germ tube antibodies for the diagnosis and therapeutic monitoring of invasive candidiasis in neutropenic adult patients. Rev Iberoam.Micol. 2006;23(4):209-215.
Reyna-Villasmil, N., Bermudez-Pirela, V., Mengual-Moreno, E., Arias, N., Cano-Ponce, C., Leal-Gonzalez, E., Souki, A., Inglett, G. E., Israili, Z. H., Hernandez-Hernandez, R., Valasco, M., and Arraiz, N. Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia. Am J Ther 2007;14(2):203-212.
Granfeldt, Y., Nyberg, L., and Bjorck, I. Muesli with 4 g oat beta-glucans lowers glucose and insulin responses after a bread meal in healthy subjects. Eur.J.Clin.Nutr. 2008;62(5):600-607.
Kelly, S. A., Summerbell, C. D., Brynes, A., Whittaker, V., and Frost, G. Wholegrain cereals for coronary heart disease. Cochrane.Database.Syst.Rev. 2007;(2):CD005051.
Sable, C. A., Strohmaier, K. M., and Chodakewitz, J. A. Advances in antifungal therapy. Annu.Rev.Med. 2008;59:361-379.
Panahi, S., Ezatagha, A., Temelli, F., Vasanthan, T., and Vuksan, V. Beta-glucan from two sources of oat concentrates affect postprandial glycemia in relation to the level of viscosity. J.Am.Coll.Nutr. 2007;26(6):639-644.
Volman, J. J., Ramakers, J. D., and Plat, J. Dietary modulation of immune function by beta-glucans. Physiol Behav. 5-23-2008;94(2):276-284.
Mean, M., Marchetti, O., and Calandra, T. Bench-to-bedside review: Candida infections in the intensive care unit. Crit Care 2008;12(1):204.
Egan, L., Connolly, P., Wheat, L. J., Fuller, D., Dais, T. E., Knox, K. S., and Hage, C. A. Histoplasmosis as a cause for a positive Fungitell (1 --> 3)-beta-D-glucan test. Med.Mycol. 2008;46(1):93-95.
Sadiq, Butt M., Tahir-Nadeem, M., Khan, M. K., Shabir, R., and Butt, M. S. Oat: unique among the cereals. Eur.J.Nutr. 2008;47(2):68-79.
Theuwissen, E. and Mensink, R. P. Water-soluble dietary fibers and cardiovascular disease. Physiol Behav. 5-23-2008;94(2):285-292.
Biorklund, M., Holm, J., and Onning, G. Serum lipids and postprandial glucose and insulin levels in hyperlipidemic subjects after consumption of an oat beta-glucan-containing ready meal. Ann.Nutr.Metab 2008;52(2):83-90.
Krajicek, B. J., Limper, A. H., and Thomas, C. F., Jr. Advances in the biology, pathogenesis and identification of Pneumocystis pneumonia. Curr.Opin.Pulm.Med. 2008;14(3):228-234.
Scully, E. P., Baden, L. R., and Katz, J. T. Fungal brain infections. Curr.Opin.Neurol. 2008;21(3):347-352.
Maki, K. C., Davidson, M. H., Witchger, M. S., Dicklin, M. R., and Subbaiah, P. V. Effects of high-fiber oat and wheat cereals on postprandial glucose and lipid responses in healthy men. Int.J.Vitam.Nutr.Res. 2007;77(5):347-356.
Nieman, D. C. Immunonutrition support for athletes. Nutr.Rev. 2008;66(6):310-320.
Nieman, D. C., Henson, D. A., McMahon, M., Wrieden, J. L., Davis, J. M., Murphy, E. A., Gross, S. J., McAnulty, L. S., and Dumke, C. L. Beta-glucan, immune function, and upper respiratory tract infections in athletes. Med.Sci.Sports Exerc. 2008;40(8):1463-1471.
Alminger, M. and Eklund-Jonsson, C. Whole-grain cereal products based on a high-fibre barley or oat genotype lower post-prandial glucose and insulin responses in healthy humans. Eur.J.Nutr. 2008;47(6):294-300.
Weitberg, A. B. A phase I/II trial of beta-(1,3)/(1,6) D-glucan in the treatment of patients with advanced malignancies receiving chemotherapy. J.Exp.Clin.Cancer Res. 2008;27:40.
Nazare, J. A., Normand, S., Oste, Triantafyllou A., Brac, de la Perriere, Desage, M., and Laville, M. Modulation of the postprandial phase by beta-glucan in overweight subjects: effects on glucose and insulin kinetics. Mol.Nutr.Food Res. 2009;53(3):361-369.
Bazzano, L. A. Effects of soluble dietary fiber on low-density lipoprotein cholesterol and coronary heart disease risk. Curr.Atheroscler.Rep. 2008;10(6):473-477.
Hlebowicz, J., Darwiche, G., Bjorgell, O., and Almer, L. O. Effect of muesli with 4 g oat beta-glucan on postprandial blood glucose, gastric emptying and satiety in healthy subjects: a randomized crossover trial. J Am Coll.Nutr 2008;27(4):470-475.
Theuwissen, E., Plat, J., and Mensink, R. P. Consumption of oat beta-glucan with or without plant stanols did not influence inflammatory markers in hypercholesterolemic subjects. Mol.Nutr.Food Res. 2009;53(3):370-376.
Hachem, R. Y., Kontoyiannis, D. P., Chemaly, R. F., Jiang, Y., Reitzel, R., and Raad, I. Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J.Clin.Microbiol. 2009;47(1):129-133.
Jenkins, D. J., Nguyen, T. H., Kendall, C. W., Faulkner, D. A., Bashyam, B., Kim, I. J., Ireland, C., Patel, D., Vidgen, E., Josse, A. R., Sesso, H. D., Burton-Freeman, B., Josse, R. G., Leiter, L. A., and Singer, W. The effect of strawberries in a cholesterol-lowering dietary portfolio. Metabolism 2008;57(12):1636-1644.
Yan, J., Allendorf, D. J., Li, B., Yan, R., Hansen, R., and Donev, R. The role of membrane complement regulatory proteins in cancer immunotherapy. Adv.Exp.Med.Biol. 2008;632:159-174.
Ohno, N. [Structure and function of fungal cell wall]. Nihon Rinsho 2008;66(12):2268-2272.
Kakeya, H. and Kohno, S. [Clinically documented fungal infections]. Nihon Rinsho 2008;66(12):2299-2304.
Gautier, S., Xhauflaire-Uhoda, E., Gonry, P., and Pierard, G. E. Chitin-glucan, a natural cell scaffold for skin moisturization and rejuvenation. Int.J.Cosmet.Sci. 2008;30(6):459-469.
Driscoll, M., Hansen, R., Ding, C., Cramer, D. E., and Yan, J. Therapeutic potential of various beta-glucan sources in conjunction with anti-tumor monoclonal antibody in cancer therapy. Cancer Biol.Ther. 2009;8(3):218-225.
Juvonen, K. R., Purhonen, A. K., Salmenkallio-Marttila, M., Lahteenmaki, L., Laaksonen, D. E., Herzig, K. H., Uusitupa, M. I., Poutanen, K. S., and Karhunen, L. J. Viscosity of oat bran-enriched beverages influences gastrointestinal hormonal responses in healthy humans. J Nutr 2009;139(3):461-466.
Kim, H., Stote, K. S., Behall, K. M., Spears, K., Vinyard, B., and Conway, J. M. Glucose and insulin responses to whole grain breakfasts varying in soluble fiber, beta-glucan: a dose response study in obese women with increased risk for insulin resistance. Eur.J Nutr 2009;48(3):170-175.
Koray, M., Ak, G., Kurklu, E., Tanyeri, H., Aydin, F., Oguz, F. S., Temurhan, S., Ciltci, H., Carin, M., Onal, A. E., and Ozdilli, K. The effect of beta-glucan on recurrent aphthous stomatitis. J Altern.Complement Med 2009;15(2):111-112.
Liatis, S., Tsapogas, P., Chala, E., Dimosthenopoulos, C., Kyriakopoulos, K., Kapantais, E., and Katsilambros, N. The consumption of bread enriched with betaglucan reduces LDL-cholesterol and improves insulin resistance in patients with type 2 diabetes. Diabetes Metab 2009;35(2):115-120.
Talati, R., Baker, W. L., Pabilonia, M. S., White, C. M., and Coleman, C. I. The effects of barley-derived soluble fiber on serum lipids. Ann.Fam.Med. 2009;7(2):157-163.
Willis, H. J., Eldridge, A. L., Beiseigel, J., Thomas, W., and Slavin, J. L. Greater satiety response with resistant starch and corn bran in human subjects. Nutr Res 2009;29(2):100-105.
Lyly, M., Liukkonen, K. H., Salmenkallio-Marttila, M., Karhunen, L., Poutanen, K., and Lahteenmaki, L. Fibre in beverages can enhance perceived satiety. Eur.J.Nutr. 2009;48(4):251-258.
Chen, J. and Raymond, K. Beta-glucans in the treatment of diabetes and associated cardiovascular risks. Vasc.Health Risk Manag. 2008;4(6):1265-1272.
Chandrasekar, P. Invasive mold infections: recent advances in management approaches. Leuk.Lymphoma 2009;50(5):703-715.
Liu, J., Gunn, L., Hansen, R., and Yan, J. Combined yeast-derived beta-glucan with anti-tumor monoclonal antibody for cancer immunotherapy. Exp.Mol.Pathol. 2009;86(3):208-214.
Almyroudis, N. G. and Segal, B. H. Prevention and treatment of invasive fungal diseases in neutropenic patients. Curr.Opin.Infect.Dis. 2009;22(4):385-393.
Chan, G. C., Chan, W. K., and Sze, D. M. The effects of beta-glucan on human immune and cancer cells. J.Hematol.Oncol. 2009;2:25.
Liu, J., Gunn, L., Hansen, R., and Yan, J. Yeast-derived beta-glucan in combination with anti-tumor monoclonal antibody therapy in cancer. Recent Pat Anticancer Drug Discov. 2009;4(2):101-109.
Rondanelli, M., Opizzi, A., and Monteferrario, F. [The biological activity of beta-glucans]. Minerva Med. 2009;100(3):237-245.
Isoda, N., Eguchi, Y., Nukaya, H., Hosho, K., Suga, Y., Suga, T., Nakazawa, S., and Sugano, K. Clinical efficacy of superfine dispersed lentinan (beta-1,3-glucan) in patients with hepatocellular carcinoma. Hepatogastroenterology 2009;56(90):437-441.
Kataoka, H., Shimura, T., Mizoshita, T., Kubota, E., Mori, Y., Mizushima, T., Wada, T., Ogasawara, N., Tanida, S., Sasaki, M., Togawa, S., Sano, H., Hirata, Y., Ikai, M., Mochizuki, H., Seno, K., Itoh, S., Kawai, T., and Joh, T. Lentinan with S-1 and paclitaxel for gastric cancer chemotherapy improve patient quality of life. Hepatogastroenterology 2009;56(90):547-550.
Hazama, S., Watanabe, S., Ohashi, M., Yagi, M., Suzuki, M., Matsuda, K., Yamamoto, T., Suga, Y., Suga, T., Nakazawa, S., and Oka, M. Efficacy of orally administered superfine dispersed lentinan (beta-1,3-glucan) for the treatment of advanced colorectal cancer. Anticancer Res 2009;29(7):2611-2617.
Cushion, M. T. and Walzer, P. D. Preclinical drug discovery for new anti-pneumocystis compounds. Curr.Med.Chem. 2009;16(20):2514-2530.
Vitaglione, P., Lumaga, R. B., Stanzione, A., Scalfi, L., and Fogliano, V. beta-Glucan-enriched bread reduces energy intake and modifies plasma ghrelin and peptide YY concentrations in the short term. Appetite 2009;53(3):338-344.
Thondre, P. S. and Henry, C. J. High-molecular-weight barley beta-glucan in chapatis (unleavened Indian flatbread) lowers glycemic index. Nutr Res 2009;29(7):480-486.
Regand, A., Tosh, S. M., Wolever, T. M., and Wood, P. J. Physicochemical properties of beta-glucan in differently processed oat foods influence glycemic response. J Agric.Food Chem 10-14-2009;57(19):8831-8838.
Beck, E. J., Tosh, S. M., Batterham, M. J., Tapsell, L. C., and Huang, X. F. Oat beta-glucan increases postprandial cholecystokinin levels, decreases insulin response and extends subjective satiety in overweight subjects. Mol.Nutr.Food Res. 2009;53(10):1343-1351.
Mello, V. D. and Laaksonen, D. E. [Dietary fibers: current trends and health benefits in the metabolic syndrome and type 2 diabetes]. Arq Bras.Endocrinol.Metabol. 2009;53(5):509-518.
Cugnet-Anceau, C., Nazare, J. A., Biorklund, M., Le, Coquil E., Sassolas, A., Sothier, M., Holm, J., Landin-Olsson, M., Onning, G., Laville, M., and Moulin, P. A controlled study of consumption of beta-glucan-enriched soups for 2 months by type 2 diabetic free-living subjects. Br.J.Nutr. 2010;103(3):422-428.
Beck, E. J., Tapsell, L. C., Batterham, M. J., Tosh, S. M., and Huang, X. F. Increases in peptide Y-Y levels following oat beta-glucan ingestion are dose-dependent in overweight adults. Nutr.Res. 2009;29(10):705-709.
Beck, E. J., Tapsell, L. C., Batterham, M. J., Tosh, S. M., and Huang, X. F. Oat beta-glucan supplementation does not enhance the effectiveness of an energy-restricted diet in overweight women. Br.J.Nutr. 2010;103(8):1212-1222.
Pietrantoni, E., Signore, F., Berardi, G., Donadio, F., and Donadio, C. [Role of beta-glucan in the treatment of recurrent candidiasis and HPV-correlated lesions and reparative process of epidermis]. Minerva Ginecol. 2010;62(1):1-5.
Lyly, M., Ohls, N., Lahteenmaki, L., Salmenkallio-Marttila, M., Liukkonen, K. H., Karhunen, L., and Poutanen, K. The effect of fibre amount, energy level and viscosity of beverages containing oat fibre supplement on perceived satiety. Food Nutr.Res. 2010;54
Melo, L. H. [Echinocandins and the 2009 guidelines for treatment of candidiasis]. Drugs Today (Barc.) 2010;46 Suppl B:7-12.
Juvonen, K. R., Salmenkallio-Marttila, M., Lyly, M., Liukkonen, K. H., Lahteenmaki, L., Laaksonen, D. E., Uusitupa, M. I., Herzig, K. H., Poutanen, K. S., and Karhunen, L. J. Semisolid meal enriched in oat bran decreases plasma glucose and insulin levels, but does not change gastrointestinal peptide responses or short-term appetite in healthy subjects. Nutr.Metab Cardiovasc.Dis. 2011;21(9):748-756.
Giacosa, A. and Rondanelli, M. The right fiber for the right disease: an update on the psyllium seed husk and the metabolic syndrome. J.Clin.Gastroenterol. 2010;44 Suppl 1:S58-S60.
Cabezas, J., Albaina, O., Montanez, D., Sevilla, M. J., Moragues, M. D., and Ponton, J. Potential of anti-Candida antibodies in immunoprophylaxis. Immunotherapy. 2010;2(2):171-183.
Wolever, T. M., Tosh, S. M., Gibbs, A. L., Brand-Miller, J., Duncan, A. M., Hart, V., Lamarche, B., Thomson, B. A., Duss, R., and Wood, P. J. Physicochemical properties of oat beta-glucan influence its ability to reduce serum LDL cholesterol in humans: a randomized clinical trial. Am.J.Clin.Nutr. 2010;92(4):723-732.
Vitaglione, P., Lumaga, R. B., Montagnese, C., Messia, M. C., Marconi, E., and Scalfi, L. Satiating effect of a barley beta-glucan-enriched snack. J.Am.Coll.Nutr. 2010;29(2):113-121.
Rylander, R. Organic dust induced pulmonary disease - the role of mould derived beta-glucan. Ann.Agric.Environ.Med. 2010;17(1):9-13.
Nilsson, A. C., Ostman, E. M., Knudsen, K. E., Holst, J. J., and Bjorck, I. M. A cereal-based evening meal rich in indigestible carbohydrates increases plasma butyrate the next morning. J.Nutr. 2010;140(11):1932-1936.
Chillo, S., Ranawana, D. V., Pratt, M., and Henry, C. J. Glycemic response and glycemic index of semolina spaghetti enriched with barley beta-glucan. Nutrition 2011;27(6):653-658.
Bobovcak, M., Kuniakova, R., Gabriz, J., and Majtan, J. Effect of Pleuran (beta-glucan from Pleurotus ostreatus) supplementation on cellular immune response after intensive exercise in elite athletes. Appl.Physiol Nutr.Metab 2010;35(6):755-762.
Yoshida, K., Shoji, H., Takuma, T., and Niki, Y. Clinical viability of Fungitell, a new (1-->3)-beta-D: -glucan measurement kit, for diagnosis of invasive fungal infection, and comparison with other kits available in Japan. J.Infect.Chemother. 2011;17(4):473-477.
Bergendiova, K., Tibenska, E., and Majtan, J. Pleuran (beta-glucan from Pleurotus ostreatus) supplementation, cellular immune response and respiratory tract infections in athletes. Eur.J.Appl.Physiol 2011;111(9):2033-2040.
Katragkou, A. and Roilides, E. Best practice in treating infants and children with proven, probable or suspected invasive fungal infections. Curr.Opin.Infect.Dis. 2011;24(3):225-229.
Tiwari, U. and Cummins, E. Meta-analysis of the effect of beta-glucan intake on blood cholesterol and glucose levels. Nutrition 2011;27(10):1008-1016.
Rondanelli, M., Opizzi, A., Monteferrario, F., Klersy, C., Cazzola, R., and Cestaro, B. Beta-glucan- or rice bran-enriched foods: a comparative crossover clinical trial on lipidic pattern in mildly hypercholesterolemic men. Eur.J.Clin.Nutr. 2011;65(7):864-871.
Turunen, K., Tsouvelakidou, E., Nomikos, T., Mountzouris, K. C., Karamanolis, D., Triantafillidis, J., and Kyriacou, A. Impact of beta-glucan on the faecal microbiota of polypectomized patients: a pilot study. Anaerobe. 2011;17(6):403-406.
Demark-Wahnefried, W., Bowering, J., and Cohen, P. S. Reduced serum cholesterol with dietary change using fat-modified and oat bran supplemented diets. J.Am.Diet.Assoc. 1990;90(2):223-229.
Thondre, P. S. and Henry, C. J. Effect of a low molecular weight, high-purity beta-glucan on in vitro digestion and glycemic response. Int.J.Food Sci.Nutr. 2011;62(7):678-684.
Othman, R. A., Moghadasian, M. H., and Jones, P. J. Cholesterol-lowering effects of oat beta-glucan. Nutr.Rev. 2011;69(6):299-309.
Gunness, P. and Gidley, M. J. Mechanisms underlying the cholesterol-lowering properties of soluble dietary fibre polysaccharides. Food Funct. 2010;1(2):149-155.
Ciacci, C., Franceschi, F., Purchiaroni, F., Capone, P., Buccelletti, F., Iacomini, P., Ranaudo, A., Andreozzi, P., Tondi, P., Gentiloni, Silveri N., Gasbarrini, A., and Gasbarrini, G. Effect of beta-glucan, inositol and digestive enzymes in GI symptoms of patients with IBS. Eur.Rev.Med.Pharmacol.Sci. 2011;15(6):637-643.
Charlton, K. E., Tapsell, L. C., Batterham, M. J., O'Shea, J., Thorne, R., Beck, E., and Tosh, S. M. Effect of 6 weeks' consumption of beta-glucan-rich oat products on cholesterol levels in mildly hypercholesterolaemic overweight adults. Br.J.Nutr. 2012;107(7):1037-1047.
Mitsou, E. K., Kirtzalidou, E., Pramateftaki, P., and Kyriacou, A. Antibiotic resistance in faecal microbiota of Greek healthy infants. Benef.Microbes. 2010;1(3):297-306.
Hofer, M. and Pospisil, M. Modulation of animal and human hematopoiesis by beta-glucans: a review. Molecules. 2011;16(9):7969-7979.
Lesher, A. P., Curry, R. H., Evans, J., Smith, V. A., Fitzgerald, M. T., Cina, R. A., Streck, C. J., and Hebra, A. V. Effectiveness of Biobrane for treatment of partial-thickness burns in children. J.Pediatr.Surg. 2011;46(9):1759-1763.
Damiani, V., Di, Carlo M., Grappasonni, G., Di, Domenico R., and Dominici, P. Efficacy of a new medical device based on colloidal silver and carbossimetyl beta glucan in treatment of upper airways disease in children. Minerva Pediatr. 2011;63(5):347-354.
Barone, Lumaga R., Azzali, D., Fogliano, V., Scalfi, L., and Vitaglione, P. Sugar and dietary fibre composition influence, by different hormonal response, the satiating capacity of a fruit-based and a beta-glucan-enriched beverage. Food Funct. 2012;3(1):67-75.
Wolever, T. M., Gibbs, A. L., Brand-Miller, J., Duncan, A. M., Hart, V., Lamarche, B., Tosh, S. M., and Duss, R. Bioactive oat beta-glucan reduces LDL cholesterol in Caucasians and non-Caucasians. Nutr.J. 2011;10:130.
Borneo, R. and Leon, A. E. Whole grain cereals: functional components and health benefits. Food Funct. 2012;3(2):110-119.
Gaullier, J. M., Sleboda, J., Ofjord, E. S., Ulvestad, E., Nurminiemi, M., Moe, C., Tor, A., and Gudmundsen, O. Supplementation with a soluble beta-glucan exported from Shiitake medicinal mushroom, Lentinus edodes (Berk.) singer mycelium: a crossover, placebo-controlled study in healthy elderly. Int.J.Med.Mushrooms. 2011;13(4):319-326.
Ostrosky-Zeichner, L. Invasive mycoses: diagnostic challenges. Am.J.Med. 2012;125(1 Suppl):S14-S24.
Lamoth, F., Cruciani, M., Mengoli, C., Castagnola, E., Lortholary, O., Richardson, M., and Marchetti, O. beta-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin.Infect.Dis. 3-1-2012;54(5):633-643.
Lattimer, J. M. and Haub, M. D. Effects of dietary fiber and its components on metabolic health. Nutrients. 2010;2(12):1266-1289.
Nelson, E. D., Ramberg, J. E., Best, T., and Sinnott, R. A. Neurologic effects of exogenous saccharides: a review of controlled human, animal, and in vitro studies. Nutr.Neurosci. 2012;15(4):149-162.
Cloetens, L., Ulmius, M., Johansson-Persson, A., Akesson, B., and Onning, G. Role of dietary beta-glucans in the prevention of the metabolic syndrome. Nutr.Rev. 2012;70(8):444-458.
Singh, R., De, S., and Belkheir, A. Avena sativa (Oat), a potential neutraceutical and therapeutic agent: an overview. Crit Rev.Food Sci.Nutr. 2013;53(2):126-144.
Majtan, J. Pleuran (beta-glucan from Pleurotus ostreatus ): an effective nutritional supplement against upper respiratory tract infections? Med.Sport Sci. 2012;59:57-61.
Beer, M. U., Arrigoni, E., and Amado, R. Effects of oat gum on blood cholesterol levels in healthy young men. Eur.J.Clin.Nutr. 1995;49(7):517-522.
Hallfrisch, J., Scholfield, D. J., and Behall, K. M. Diets containing soluble oat extracts improve glucose and insulin responses of moderately hypercholesterolemic men and women. Am.J Clin.Nutr. 1995;61(2):379-384.
Vetvicka, V., Thornton, B. P., and Ross, G. D. Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J.Clin.Invest 7-1-1996;98(1):50-61.
Behall, K. M., Scholfield, D. J., and Hallfrisch, J. Effect of beta-glucan level in oat fiber extracts on blood lipids in men and women. J.Am.Coll.Nutr. 1997;16(1):46-51.
Uusitupa, M. I., Miettinen, T. A., Sarkkinen, E. S., Ruuskanen, E., Kervinen, K., and Kesaniemi, Y. A. Lathosterol and other non-cholesterol sterols during treatment of hypercholesterolaemia with beta-glucan-rich oat bran. Eur.J.Clin.Nutr. 1997;51(9):607-611.
Estrada, A., Yun, C. H., Van Kessel, A., Li, B., Hauta, S., and Laarveld, B. Immunomodulatory activities of oat beta-glucan in vitro and in vivo. Microbiol.Immunol. 1997;41(12):991-998.
Yun, C. H., Estrada, A., Van Kessel, A., Gajadhar, A., Redmond, M., and Laarveld, B. Immunomodulatory effects of oat beta-glucan administered intragastrically or parenterally on mice infected with Eimeria vermiformis. Microbiol.Immunol. 1998;42(6):457-465.
Hetland and Geir. Anti-infective action of immuno-modulating polysaccharides (beta-glucan and plantago major L. Pectin) against intracellular (mycobacteria sp.) and extracellular (streptococcus pneumoniae sp.) respiratory pathogens. Curr.Med.Chem.- Anti-infective Agents 2003;2(2):135-147.
Okamoto, Takashil, Kodoi, Riel, Nonaka, Yujil, Fukuda, Itosukol, Hashimoto, Kanazawa, Kazukil, Mizuno, Masashi, and Ashida Hitoshi. Lentinan from shiitake mushroom (Lentinus edodes) supresses expression of cytochrome p450 1A subfamily in the mouse liver. Biofactors 2004;21(1/4):407-410.
Zhuang, C. Medicinal value of culinary-medicinal Maitake Mushroom Grifola frondosa. International Journal of Medicinal Mushrooms 2004;6(4):287-314.
Tosh SM, Brummer Y Wolever TMS Wood PJ. Glycemic response to oat bran muf?ns treated to vary molecular weight of b-glucan. Cereal Chem 2008;85:211-217.
Talbott SM, Talbott JA Talbott TL Dingler E. Beta-Glucan supplementation, allergy symptoms, and quality of life in self-described ragweed allergy sufferers. Food Science & Nutrition 2013;1(1):1-12.
Talbott S, Talbott J. Effect of beta 1,3/1,6 glucan on respiratory tract infection symptoms and mood state in marathon athletes. J Sports Sci Med 2009;8(4):509-515.
Chen, CY, Milbury, PE, Kwak, HK, Collins, FW, Samuel, P, and Blumberg, JB. Avenanthramides and phenolic acids from oats are bioavailable and act synergistically with vitamin C to enhance hamster and human LDL resistance to oxidation. J Nutr 2004;134:1459-1466.
Regand, A., Chowdhury, Z., Tosh, S. M., Wolever, T. M., and Wood, P. The molecular weight, solubility and viscosity of oat beta-glucan affect human glycemic response by modifying starch digestibility. Food Chemistry 2011;129(2):297-304.
Cavallero A, Empilli S Brighenti F Stanca AM. High (1/3, 1/4)-b-glucan barley fractions in bread making and their effects on human glycemic response. J Cereal Sci 2002;36:59-66.
Hallfrisch J, Schol eld DJ Behall KM. Physiological responses of men and women to barley and oat extracts (Nu-trim X). II. Comparison of glucose and insulin responses. Cereal Chem 2003;80:80-83.
Lan-Pidhainy X, Brummer Y Tosh SM Wolever TM Wood PJ. Reducing beta-glucan solubility in oat bran muf?ns by freeze-thaw treatment attenuates its hypoglycaemic effect. Cereal Chem 2007;84(512):517.
Ostman E, Rossi E Larsson H Brighenti F Bj orck I. Glucose and insulin responses in healthy men to barley bread with different levels of (1/3; 1/4)-b-glucans; predictions using ?uidity measurements of in vitro enzyme digests. J Cereal Sci 2006;43:230-235.
Yokoyama WH, Hudson CA Knuckles BE Chiu MCM Sayre RN Turnlund J. Schneeman RO. Effect of barley b-glucan in durum wheat pasta on human glycaemic response. Cereal Chem 1997;74:293-296.
Olsson J, Sundberg B. Clinical Study Report. Effects of boiled, flaked, milled barley powder product (Aktiv) on LDL-, HDL- and total cholesterol, triglycerides, glucose, insulin and HS-CRP levels in healthy hypercholesterolemic men and women. Centre for Human Studies of Foodstuffs 2005;
Sundberg B. Cholesterol lowering effects of a barley fibre flake products. AgroGOOD Industry Hi-tech 2008;19:14-17.
Johnston LRH, Hunninghake DB Schultz K Westereng B. Cholesterol-lowering benefits of a whole grain oat ready to eat cereal. Nutr Clin Care. 1998;1:6-12.
Pomeroy, R, Cehun-Aders, S, Nestel, M, and Tupper, P. Oat beta-glucan lowers total and LDL-cholesterol. Australian Journal of Nutrition and Dietetics 2001;58(1):151-155.
Kim H, Behall KM Vinyard B et al. Short-term satiety and glycemic response after consumption of whole grains with various amounts of b-glucans. Cereal Food World. 2006;51:29-33.
Mårtensson O, Biörklund M Lambo AM et al. Fermented, ropy, oat-based products reduce cholesterol levels and stimulate the bifidobacteria flora in humans. Nutr Res. 2005;25:429-442.
Yap, A and Ng, M. Immunopotentiating Properties of Lentinan (1-3)-Beta-D-glucan Extracted from culinary-medicinal shiitake mushrooms. International Journal of Medicinal Mushrooms 2003;5(4):339-359.
Amundsen, AL, Haugum, B, and Andersson, H. Changes in serum cholesterol and sterol metabolites after intake of products enriched with an oat bran concentrate with a controlled diet. Scandinavian Journal of Nutrition 2003;47 (2):68-75.
Feldman S, Schwartz HI Kalman DS Mayers A Kohrman HM Clemens R Krieger DR. Randomized phase II clinical trials of Wellmune WGP® for immune support during cold and flu season. The Journal of Applied Research 2009;9(1-2):30-42.
Peterson, DM and Qureshi, AA. Genotype and environment effects on tocols of barley and oats. Cereal Chem 1993;70:157-162.
Newman RK, Lewis SE Newman CW Boik RJ Ramage RT. Hypocholesterolemic effect of barley foods on healthy-men. Nutr Rep Int 1989;39:749-760.
El Khoury D, Cuda C, Luhovyy BL, Anderson GH. Beta glucan: health benefits in obesity and metabolic syndrome. J Nutr Metab. 2012;2012:851362.
Anttila H, Sontag-Strohm T, Salovaara H. Viscosity of beta-glucan in oat products. Agri Food Sci. 2004;13:80-87.
Akyol A, Dasgin H, Ayaz A, Buyuktuncer Z, Besler HT. ß-Glucan and dark chocolate: a randomized crossover study on short-term satiety and energy intake. Nutrients. 2014;6(9):3863-77.
Jesenak M, Hrubisko M, Majtan J, Rennerova Z, Banovcin P. Anti-allergic effect of Pleuran (ß-glucan from Pleurotus ostreatus) in children with recurrent respiratory tract infections. Phytother Res. 2014;28(3):471-4.
Leentjens J, Quintin J, Gerretsen J, et al. The effects of orally administered Beta-glucan on innate immune responses in humans, a randomized open-label intervention pilot-study. PLoS One. 2014;9(9):e108794.
McFarlin BK, Carpenter KC, Davidson T, McFarlin MA. Baker's yeast beta glucan supplementation increases salivary IgA and decreases cold/flu symptomatic days after intense exercise. J Diet Suppl. 2013;10(3):171-83.
Whitehead A, Beck EJ, Tosh S, Wolever TM. Cholesterol-lowering effects of oat ß-glucan: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2014;100(6):1413-21.
Frid A, Tura A, Pacini G, Ridderstråle M. Effect of oral pre-meal administration of betaglucans on glycaemic control and variability in subjects with type 1 diabetes. Nutrients 2017;9(9). pii:E1004.
Spagnuolo R, Cosco C, Mancina RM, et al. Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome. Eur Rev Med Pharmacol Sci 2017;21(2 Suppl):102-7.
Thomas M, Sadjadian P, Kollmeier J, et al. A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3-1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer. Invest New Drugs 2017;35(3):345-58.
Tessari P, Lante A. A multifunctional bread rich in beta glucans and low in starch improves metabolic control in type 2 diabetes: a controlled trial. Nutrients 2017;9(3). pii:E297.
Ho HV, Sievenpiper JL, Zurbau A, et al. The effect of oat ß-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials. Br J Nutr 2016;116(8):1369-82.
Segal NH, Gada P, Senzer N, Gargano MA, Patchen ML, Saltz LB. A phase II efficacy and safety, open-label, multicenter study of imprime PGG injection in combination with cetuximab in patients with stage IV KRAS-mutant colorectal cancer. Clin Colorectal Cancer 2016;15(3):222-7.
Jesenak M, Urbancek S, Majtan J, Banovcin P, Hercogova J. ß-Glucan-based cream (containing pleuran isolated from pleurotus ostreatus) in supportive treatment of mild-to-moderate atopic dermatitis. J Dermatolog Treat 2016;27(4):351-4.
Aoe S, Ichinose Y, Kohyama N, et al. Effects of high ß-glucan barley on visceral fat obesity in Japanese individuals: a randomized, double-blind study. Nutrition 2017;42:1-6.
Mosikanon K, Arthan D, Kettawan A, Tungtrongchitr R, Prangthip P. Yeast ß-glucan modulates inflammation and waist circumference in overweight and obese subjects. J Diet Suppl 2017;14(2):173-85.
Ho HV, Sievenpiper JL, Zurbau A, et al. A systematic review and meta-analysis of randomized controlled trials of the effect of barley ß-glucan on LDL-C, non-HDL-C and apoB for cardiovascular disease risk reduction. Eur J Clin Nutr 2016;70(11):1239-45.